Only one currently authorized antibody treatment retains its activity against all Omicron subvariants, according to new research by scientists at Columbia University and the University of Hong Kong. The study also shows that ...
Mar 3, 2022
0
40
Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of the liver, as well as cancers of the gallbladder, and are highly likely ...
Jun 2, 2023
0
26
National clinical guidelines for the treatment of COVID-19 vary significantly around the world, with under-resourced countries the most likely to diverge from gold standard (World Health Organization; WHO) treatment recommendations, ...
Apr 22, 2024
1
17
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe cases of the disease, ...
May 22, 2013
0
0
Don't be alarmed if you are experiencing seasonal allergies for the first time. While hay fever—also known as allergic rhinitis—often begins in childhood, more adults are being diagnosed, according to the Centers for ...
May 6, 2022
0
6
(Medical Xpress)—Monash Institute of Medical Research scientists may have discovered a way of blocking stomach tumours from growing and spreading, according to a paper published in the highly-prestigious journal Cancer ...
Oct 16, 2012
0
0
DEAR MAYO CLINIC: My cousin was diagnosed with COVID-19 last summer and received monoclonal antibody therapy. Another one of my cousins recently was diagnosed with COVID-19 but did not get that treatment. What treatments ...
Feb 9, 2022
0
13
The largest study of patients with severe asthma to date, published in the Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50 percent reduction ...
Aug 16, 2012
0
0
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells. However, in the more than 20 years since ...
Aug 13, 2020
0
88
A retrovirus known as human T-cell lymphotropic virus type 1 (HTLV-1) is known to cause a number of diseases, including inflammatory diseases of the eye. Recently, researchers in Japan have investigated an antibody treatment ...
Feb 21, 2023
0
2
